Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Promotion of a Standardized Diagnostic and Treatment Pathway for Polycystic Ovary Syndrome in Primary Care Based on a Bidirectional Referral System

NCT07350876 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT07350876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07350876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Promotion of a Standardized Diagnostic and Treatment Pathway for Polycystic Ovary Syndrome in Primary Care Based on a Bidirectional Referral System
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Overall status
Completed
Start date
October 18, 2024
Completion date
December 13, 2025
Enrollment
227 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic ovary syndrome (pcos)